Atlas Trials

Rituximab in Membranous Nephropathy

Clinical trial NCT00425217 · COMPLETED

Trial details

NCT number
NCT00425217
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Membranous Nephropathy
Start date
2004-08-01
Primary completion
2007-04-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.